1996
DOI: 10.1016/0968-0896(96)00147-2
|View full text |Cite
|
Sign up to set email alerts
|

A new class of HIV-1 protease inhibitor: The crystallographic structure, inhibition and chemical synthesis of an aminimide peptide isostere

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
7
0

Year Published

1998
1998
2021
2021

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 28 publications
(7 citation statements)
references
References 36 publications
0
7
0
Order By: Relevance
“…The 1XL2 structure contains a ligand based on a pyrrolidinemethaneamine scaffold that adopts a unique and unexpected binding mode (59). The other singleton, PDB ID 3AID, was based on an aminimide peptide isothere (60). In these two cases, the binding mode of the ligand places a phenyl group into a pocket that only these two ligands occupy (see Figure 2).…”
Section: Hiv Protease Binding Site Analysismentioning
confidence: 99%
“…The 1XL2 structure contains a ligand based on a pyrrolidinemethaneamine scaffold that adopts a unique and unexpected binding mode (59). The other singleton, PDB ID 3AID, was based on an aminimide peptide isothere (60). In these two cases, the binding mode of the ligand places a phenyl group into a pocket that only these two ligands occupy (see Figure 2).…”
Section: Hiv Protease Binding Site Analysismentioning
confidence: 99%
“…When the app's user interface has been explained, the students can work on the tasks mentioned above in groups of 2-3 students for about 15-20 min. Supplementary Video S1 shows a video sequence of a collaborative task on the molecule with the pdb code 3AID [23] to give an impression of how two overlaying representations are used to identify different aspects of protein structures. The whole procedure is visualized in Figure 3.…”
Section: Contents and Structure Of The Teaching Unitmentioning
confidence: 99%
“…A novel aminimide transition‐state analogue has been identified and utilized as a general aspartyl protease pharmacophore 55. This isostere was designed to mimic the placement of hydrogen‐bonding atoms in the aspartyl protease active site, while being resistant to proteolysis.…”
Section: Protease Inhibitor Designmentioning
confidence: 99%